Learn More
Medchemexpress LLC HJ445A | 3032441-59-8 | 98.3% | 445.52 | 5 MG

Supplier: Medchemexpress LLC HY1630845MG
HJ445A is a potent MYOF inhibitor that binds to the MYOF-C2D domain with a KD of 0.17 μM. It repressed the proliferation of gastric cancer cells with IC50 values of 0.16 and 0.14 μM in MGC803 and MKN45, respectively. HJ445A shows superior antitumor efficacy in vivo and is suitable for cancer research.
- Potent MYOF inhibitor
- Represses proliferation of gastric cancer cells
- Demonstrates superior antitumor efficacy in vivo
- Can be used for cancer research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.